Related by context. All words. (Click for frequent words.) 66 Azactam 65 DOVONEX 65 Components Segment 62 Programmer Paradise segment 62 Klean Prep TM 61 Wellbutrin XL R 61 Forlax ® 60 PENTASA 60 BLU U R 60 Smecta ® 60 Orthovisc ® 60 AGY Asia 60 Maxipime 60 HealthStream Learning 59 Ribavirin royalties 59 Partnered Brands segment 59 noninterest expense decreased 59 Recurring royalties 59 Lasertel subsidiary 59 operatingincome 59 Actimmune R 59 Dorzolamide 59 Orthovisc R 59 Elestat 59 Novogyne 59 continuingoperations 59 Evaporative Cooling segment 59 Hesperion acquisition 59 TACLONEX 59 ZANAFLEX CAPSULES 59 PRAVACHOL R 58 ABELCET 58 BioMarin Genzyme LLC 58 STRIANT 58 Anhui Jucheng 58 PDP MLR 58 loss NOL carryforward 58 BD Biosciences segment 58 AMPAC ISP Holdings 58 CECT branded handsets 58 generic clopidogrel bisulfate 58 Tecstar Automotive Group 58 stock basedcompensation 58 PMPS brand 58 Currency translation effects 58 OshKosh wholesale 58 operating income1 58 SORL consolidated 58 prioryear 58 SmartMusic subscription 58 Regentek 57 Forlax R 57 Vacation Interval sales 57 generic Flomax ® 57 Angelini Labopharm 57 ended September# 57 thequarter 57 Timolol ophthalmic solution 57 Orthopaedic Implants 57 Monovisc TM 57 Oxy ER 57 Noven Therapeutics 57 Endoscopic Technologies 57 generic Adderall XR 57 2Q FY# representing 57 VANTAS 57 LIALDA MEZAVANT 57 Interest Expense Interest expense 57 Hulunbeier Beixue 57 Refractories segment 56 FUEL CHEM segment 56 Fine Chemicals segment 56 phytosterol revenues 56 Denville Scientific 56 Drivetrain segment 56 ninemonths ended 56 ALTANA Chemie 56 millioncompared 56 RAPTIVA R 56 LIFO adjustment 56 ARCALYST ® 56 Vinyls segment 56 MedSurg Equipment 56 sameperiod 56 OTTI charges 56 comparedto 56 unamortized portion 56 Non GAAP adjusted EBITDA 56 Panlab 56 Specialty Acids 56 Chemicals Segment 56 Roadway Sensors 55 PGP Acquisition 55 Replens ® 55 Nuo Hua 55 BioGlue ® 55 NuGlow 55 Domilens 55 Gross Margin Gross 55 NETg acquisition 55 Symphony GenIsis 55 4Q FY# 55 Baobaole chewable tablets 55 segments Orthopaedic Implants 55 baseband semiconductors 55 Previously Securitized Loans 55 Zanaflex tablets 55 totaled EUR#.#m 55 Newsstand Distribution Services 55 NutropinAq ® 55 3Q FY# 55 DiaMed acquisition 55 Billable headcount 55 Rmb #.# 55 noninterest expense totaled 55 Scailex Corporation 55 Cardiac Surgery Systems 55 Licorice Products segment 55 Motorhome Resorts Segment 55 Retail Leathercraft 55 nasal Cold Remedy 55 Kerastick ® 55 Kerastick 55 #.Net 55 theprior 55 MVAS gross 55 Xantic acquisition 55 RMB2 #.# 55 Noninterest expense decreased 54 Filtran 54 Polyurethanes segment 54 Near Infrared Optics 54 Somatuline ® 54 Oxandrin 54 totaled USD#.#m 54 Aloxi injection 54 disposable handpieces 54 months endedSeptember 54 AZASITE 54 Amnesteem 54 Nisisco R 54 Coating Resins 54 Ps.2 54 AmericanSingles segment 54 Preprint revenues 54 CRINONE 54 Wilhelmina Companies 54 STRIANT ® 54 Kerastick R 54 ECU netbacks 54 Coulbourn Instruments 54 quarterended 54 XYREM 54 currency remeasurement 54 BD Diagnostics segment 54 Ps.3 54 GSCT program 54 Pigments segment 54 Nascobal 54 BLU U ® 54 Huipu 54 Engineered Materials segment 54 Prepaid churn 54 Explosive Metalworking segment 54 kiwifruit puree 54 adopting SFAS #R 54 3Q FY# representing 54 MSEK -#.# 53 NTIC consolidated 53 nonoperating expense 53 ninemonths 53 BioGlue revenues 53 netincome 53 1Q FY# representing 53 Radix Isatidis 53 Engineered Products segment 53 Timeshare segment 53 netsales 53 1Q FY# 53 ARCALYST R 53 Cetrotide R 53 ascompared 53 RMB3 #.# 53 Adjusted Ebitda 53 unfavorable variances 53 nine monthsended 53 Nicomide ® 53 Wireline adjusted EBITDA 53 Xenazine ® 53 unabsorbed overhead 53 Lexiscan R 53 GBP #.#m [003] 53 Q#/# EUR [002] 53 DSG Canusa 53 undepreciated assets 53 ofapproximately 53 ev3 peripheral vascular 53 SunOpta Foods 53 MEP Joint Venture 53 Astaris joint venture 53 Pro forma adjusted EBITDA 53 Sensei Robotic Systems 53 ABILIFY R 53 Purified Phosphoric Acid 53 ASUR regulated 53 Cytec Surface Specialties 53 BUPHENYL 53 Processed Minerals 53 ORS Nasco 53 Aerostructures segment 53 GYN Surgical revenues 53 Subordinate MBS portfolio 53 FHLB borrowings decreased 53 Residential Furnishings 53 FHLB advances decreased 53 ACTONEL 53 RMB4 #.# 53 Disposable Protective Apparel 53 CECP segment 53 HIGHYAG 53 Unitrin Direct segment 53 Segment PTOI 53 Soriatane R 53 NIS#.# 53 CCXA 53 Abelcet 53 USD#.#m [007] 53 fiscal# 53 Noninterest expense totaled 52 Polymer Additives segment 52 unbilled revenue 52 PY EUR 52 subaccounts serviced 52 fracture proppant 52 Jinzhou Wanyou 52 International Leathercraft 52 Wholesale Leathercraft 52 Source Photonics 52 Scantron segment increased 52 Dal Tile segment 52 increaseof 52 Adjusted EBITDA1 52 Clindesse R 52 Specialty Chemicals Segment 52 Katonah Debt Advisors 52 Surface Specialties 52 JPY8 52 Royal Leerdam 52 Womacks Adjusted EBITDA 52 Normalized EBITDA 52 Clinical Diagnostics segment 52 RMB#.#million 52 Ps.7 52 Cold Remedy segment 52 MVAS revenues 52 IV Infusion Therapy 52 marketed workover rigs 52 Sewer Rehabilitation segment 52 Hwada 52 RYZOLT 52 proforma revenues 52 Non CWI 52 Custom folding carton 52 nonaccrual loan 52 Scantron segment 52 ELESTAT 52 MFB Corp 52 Nicomide R 52 Olefins Polyolefins 52 Scantron segment decreased 52 EUR -#.# -#.# [001] 52 Fortical 52 NBV margin 52 SWDCC 52 Recreational Accessories segments 52 recycled LDPE 52 Currency translation negatively impacted 52 LIFO inventory adjustments 52 Evoclin R 52 embolics 52 Loan Facilitation Services 52 BPLP 52 Olefins segment 52 FSAH Acquisition 52 Hönle Group 52 quarter offiscal 52 #compared 52 Teveten 52 Effect Pigments 52 intangible impairment 52 #.# perdiluted 52 Oilseeds Processing operating 52 reinsurance commutations 52 OTTI charge 52 NTIC joint ventures 52 Zero Coupon Convertible Notes 52 H1 FY# [001] 52 TRY#.# [001] 52 LIFO adjustments 52 EFT Processing Segment 52 thethird quarter 52 International Liftboats 52 STECO acquisition 52 OREO valuation 52 OCTG inventory 52 RESTASIS 52 Reimbursed expenses 52 Cinch Connectors 52 WhiteWave Morningstar 52 Lilly ICOS joint venture 51 #.#/diluted share 51 CRINONE R 51 USD #.#bln [001] 51 Performance Polymers segment 51 JPY#.# billion [002] 51 Fixed annuity 51 Specialty Engineered Alloys 51 Nonperforming loans totaled 51 generic oral contraceptives 51 barrels MMBbls 51 Copaxone ® 51 CSBU 51 unabsorbed fixed 51 Fabricated Products segment 51 receivable balances 51 DSD Dairy segment 51 Broadway Ticketing 51 accretable 51 unamortized premiums 51 Fab 3E 51 Barrett NDEx 51 Angio Seal TM 51 CRIC shareholders 51 9M FY# [002] 51 USD#.#m USD#.# per [002] 51 specialty injectables 51 FINANCIAL DETAILS 51 accounts receivable balances 51 Actient Pharmaceuticals 51 LCDP segment 51 monthsended 51 Art's Way Vessels 51 Noninterest Expense Noninterest expense 51 TOFUTTI BRANDS INC. 51 MNOK #,# 51 noncash pretax charge 51 AMK Welding 51 Bilive 51 Fiber Optics segment 51 quarter# 51 LC Bead 51 Norcraft Holdings 51 ZANAFLEX tablets shipments 51 MCDL 51 OTTI write downs 51 adjusted2 51 EURO#.# [002] 51 Dispensing Equipment 51 Individual Annuities segment 51 Specialized Products 51 debt extinguishments 51 LUCENTIS r 51 Fabricated metal 51 Sensipar R 51 Adjusted FIFO EBITDA 51 GunLink 51 XOPENEX Inhalation Solution 51 warranty accruals 51 Lubrizol Additives segment 51 Conceptus SAS 51 #.# BBtu d 51 Surface Specialties acquisition 51 normalized EBIT 51 TEB adjustment 51 Klean Prep ® 51 FSAH acquisition 51 Aldex 51 Kerastick ® revenues 51 Fanapt ® 51 Intevac Photonics revenues 51 Aircraft Modifications 51 Churn Rate 51 Partially offset 51 bakery cafe sales 51 Explosive Metalworking 51 Ps.5 51 Enventis Sector 51 ImmunoCyt TM uCyt + 51 thequarter ended 51 Oncaspar 51 Incentra LLC 51 InfuSystem Holdings Inc. 51 ARCALYST ® rilonacept 50 Specified Items 50 Pro Forma Adjusted EBITDA 50 LIFO inventory decrement 50 n#.# [002] 50 per dilutedshare 50 Exterran stockholders 50 MARRIOTT REVENUES totaled 50 Newsprint expense 50 GTSP 50 Ningbo Zhehua 50 PTOI 50 upholstery fabrics segment 50 Univeyor 50 OREO write downs 50 USD#.#m [008] 50 totaled MEUR 50 Imputed Revenue 50 NA HME 50 Filtran Microcircuits Inc. 50 impacting comparability 50 Q2 FY# [001] 50 Prepaid ARPU 50 promissory note receivable 50 b Reflects 50 iii Ps 50 Craftmade segment 50 Harland Acquisition 50 Business.com Acquisition 50 Nonperforming assets totaled 50 -#.# Mio 50 iDeclare 50 Adjusted EBIT 50 Thalomid ® 50 adjusted EBITDAR 50 NeedleTech 50 totaled EUR#.#bn 50 earnings pershare 50 Printed Circuit Materials 50 incentive accruals 50 JMP Credit 50 Optivar 50 Dismed 50 MagTex acquisition 50 inventories revalued 50 anincrease 50 Printed Products 50 gallium arsenide GaAs substrate 50 NanoKnife IRE System 50 Nabi HB 50 Order Backlog 50 LIDODERM 50 Megace R ES 50 Designer Intimates 50 MoreDirect 50 APJ region 50 Generics Segment 50 disposable TMR 50 Interest expense decreased 50 Preclinical eValuation 50 Acquired Intangible Assets 50 OLUX R clobetasol propionate 50 Thermography division 50 subsidiary ChipMOS TECHNOLOGIES 50 NutropinAq R 50 OCF margin 50 Gross Profit Gross 50 Segment EBIT 50 EURO#.# [001] 50 PV module shipments 50 Gufeng 50 NOK#.#m 50 FDIC indemnification 50 unabsorbed manufacturing 50 Commodity Margin 50 AllOne Mobile Corporation 50 NeoVisc R 50 Device Connectivity 50 RMB1 #.# 50 Crisa 50 elexis 50 acquired Brooks Eckerd 50 Oy Ovako Ab 50 RMR additions 50 #,# ADMTs 50 minus TEUR 50 OPANA franchise 50 Surfactant gross 50 Vusion 50 c Includes 50 Additive Technologies 50 NovoSeven ® 50 Deltron wholly owned 50 threemonths ended 50 Variable annuity deposits 50 MA PFFS 50 Phosphates segment 50 Positively impacting 50 Mondi Hadera Paper 50 Wholesale Leathercraft posted 50 Dane Elec Memory 50 VISaer 50 unfavorable variance 50 PRO Unlimited 50 orally bioavailable mimics 50 Xantic 50 Stendal mill 50 shippable backlog 50 Phyzyme 50 Plenexis 50 rebased revenue 50 Romaco segment 50 Composite Fibers 50 TRY#.# [005] 50 intersegment revenues 50 #.#per diluted 50 Nonaccrual loans totaled 50 Specialty Resins 50 Edict Systems 50 AGY Holding Corp. 50 pro forma adjusted EBITDA 50 Panamax Bulk Carrier 50 Order Bookings 50 Including discontinued operations 50 Mavrix Mutual Funds 50 Coatings Segment 50 hedge ineffectiveness 50 +#.# ppts 50 PictureMe Portrait Studio 49 SUSTIVA R 49 mortgage loan fundings 49 Performance Coatings segment 49 intrinsic sphincter deficiency 49 BOEd 49 Rx Pharmaceuticals 49 Fytokem 49 Wireline EBITDA 49 Mortgage Purchase Agreements 49 HealthStream Research 49 c Calculated 49 recognized ratably 49 ONEOK Partners segment 49 adjusted OIBDA margin 49 Radix Isatidis Dispersible Tablets 49 TSEK 49 Ltd. Scailex 49 adjusted EDITDA 49 Therapeutic Antibodies segment 49 Funded backlog 49 Naprelan R 49 TeamStaff Rx 49 DKK #.#bn [002] 49 CDMA WCDMA handset 49 Promotions.com subsidiary 49 Repliform R revenues 49 CLARINEX 49 Non GAAP Operating Margin 49 GC Impsat 49 inVentiv Patient Outcomes 49 Satisloh 49 Apetit Kala 49 NOI decreased 49 Supplies Distributors 49 Mr. Movens 49 date Wholesale Leathercraft 49 Resilient Flooring 49 Normalized EPS 49 Paperboard Packaging segment 49 MNOK #.# 49 RLEC adjusted EBITDA 49 Unitrin Specialty segment 49 Peripheral vascular 49 Selling Expenses 49 invoiced shipments 49 YonY 49 PhosLo R 49 PFH Holding GmbH 49 yearended December 49 inhaled treprostinil 49 Specialty Phosphates 49 neutropenia thrombocytopenia 49 nonperforming assets totaled 49 Beixue Group 49 invoiced shipment 49 Material Handling Segment 49 EBITD 49 % unannualized 49 FQ#'# 49 Optium merger 49 Ps.1 #.# 49 Gross profit 49 Specialty Chemicals segment 49 intangible impairments 49 Franklin Covey Products 49 deductible goodwill impairment 49 DAC unlocking 49 Electricity Metering 49 EBITDAO 49 Q1 #F 49 Mortgage loan originations 49 Rosebel royalty 49 Mettoni 49 Xi'an Simo 49 Onshore Downstream 49 bps YoY 49 Vyvx advertising 49 Lenovo AsiaInfo 49 JPY6 49 Deno Gold 49 GLASSIA 49 RGU additions 49 Specialty Salts 49 MEUR -#.# 49 Adjusted Timeshare 49 TSX OPM 49 TRY# [001] 49 RESTASIS ® 49 Halotron revenues 49 ¥ #.#tr 49 unconsolidated joint 49 totaled EUR#.# 49 Clarithromycin sustained release 49 Dhs1 #m 49 DPAC amortization 49 Blended churn 49 SmartCertify 49 € #.#bn [008] 49 loan outstandings 49 n#.# [001] 49 Vyvx Advertising Distribution 49 Lead Fabricating 49 Niobe ® 49 Jostens Yearbook 49 Corrugated Packaging segment 49 Duromist 49 GTL invests 49 Ps.6 49 Arlon Electronic Materials 49 CyberSecurity Solutions segment 49 OSIs 49 Operating Expenses Operating 49 GGB Bearing Technology 49 SEK -#.# [002] 49 Sturm Foods 49 adjusted1 49 BOLI COLI 49 EUR#.#million 49 Blended ARPU 49 LibertyBank Acquisition 49 9M FY# [001] 49 LIFO inventory valuation 49 EBITDA1 49 Fazenda Brasileiro Mine 49 fracture proppants 49 Items impacting comparability 49 #F YTD 49 Retransmission consent revenue 49 asset impairments restructuring 49 income allocable 49 organic RGU additions 49 Besylate 49 c Represents 49 Custom Electrical Components 48 Adjusted EBITA 48 #.#bn rub [003] 48 contractual minimums 48 Polymer Additives 48 polyvinyl chloride PVC resin 48 Second Quarter Highlights 48 LIFO reserve 48 Imagewear coalition 48 Rmb#.# [006] 48 SEK #.#M #.# 48 Jostens Scholastic 48 Specialty Injectable Pharmaceuticals 48 TRY#.# [004] 48 preneed cemetery 48 DeVenture 48 Q4 FY'# 48 7ACA 48 Seamap 48 OMT Technologies 48 RBK pulp 48 Corus Aluminum 48 Chlor Alkali segment 48 1H FY 48 currency translation 48 RASP Data Security 48 foreign currency remeasurement 48 THALOMID 48 AMH II 48 generic oral contraceptive 48 ELIOKEM 48 USD#.#m USD#.# per [001] 48 Rental Comps 48 DSR * 48 Rs.#.#cr 48 including Bclear ADV 48 palonosetron hydrochloride injection 48 Medicare Advantage MLR 48 PurCotton R products 48 EBITA amounted 48 Business Unit CSBU 48 OnVista Group 48 CalFirst Bancorp 48 postpay churn 48 Fortical royalties 48 thrombopoietin TPO 48 Industrial Castings 48 #bp YoY 48 consolidated VIE 48 StanCorp Mortgage Investors 48 ZEFFIX 48 Naston Limited 48 Vita Seafood 48 NASDAQ SCSC 48 nonreportable segment revenues 48 YTD# 48 virgin.net 48 Crosstown Traders 48 loan chargeoffs 48 BPE Segment 48 Arlon Coated Materials 48 fourth OSV newbuild 48 automobiles prev.yr. 48 pershare 48 prepaid ARPU 48 Adjusted Gross Profit 48 HIUBC 48 Recurring EBITDA 48 React NTI 48 MSR valuation adjustments 48 NeoVisc ® 48 screenprint channel 48 Equity Investees 48 Tiens USA 48 TiO2 selling 48 securitized receivables 48 Crisal 48 RAE Fushun 48 Seamap equipment 48 EUR# mn [001] 48 unrealized derivative 48 Hycamtin ® 48 Specialty Papers segment 48 Delvag 48 postpaid ARPU 48 Pro forma Adjusted EBITDA 48 SEK#.#bn [004] 48 Nonperforming assets decreased 48 neurosurgery extremity reconstruction 48 Lumificient 48 2Q FY# [001] 48 Recreational Accessories 48 Junkfood Clothing 48 ¥ #.#bn [002] 48 MAGNETIX 48 Normalized FFO 48 HCRY 48 Bioprocess Division 48 Visiting Nurse VN 48 Custom Sheet 48 Lillie Rubin chain 48 CHF#.# [001] 48 ThromCat 48 ESP Pharma 48 Radix Isatidis dispersible tablets 48 FTE staffing 48 human rabies immunoglobulin 48 Pro Forma EBITDA 48 Medco repurchased 48 Gross Addition CPGA 48 placebo dexamethasone 48 uncollectible accounts receivable 48 CLO #-# 48 Barocycler instruments 48 Stolthaven Terminals 48 Zindart 48 reagent disc 48 totaled E#.# 48 excluding divestments 48 MBOED 48 Sentigen Biosciences 48 Summarized consolidated 48 andoperating 48 theGroup 48 Gross margin 48 PMPM basis 48 Albert Heijn supermarkets 48 Scrap intake 48 R rilonacept Injection 48 client reimbursables 48 noncash impairments 48 Q4 #F 48 loan originations totaled 48 pretax noncash charges 48 Giantstone 48 Buzztime iTV Network 48 BPPR reportable segment 48 aftertax gain 48 Loss severities 48 JPY#.#bn [003] 48 Non GAAP noninterest expense 48 Surgical Implant Division 48 Depletions 47 Genco Commander 47 Postpaid ARPU 47 Innovis Entities 47 Wuhan Sungreen 47 postpaid subscriber base 47 Omacor Lovaza 47 oxycodone CR 47 neurologic dysfunction 47 Extra Ordinary Items 47 Synagis palivizumab 47 PLRMBS 47 thefourth quarter 47 USD#.#m [006] 47 quarterof 47 NYSE MIM MID 47 FARESTON ® 47 -By Cliodhna McGowan 47 NASDAQ OBCI 47 plus aztreonam 47 mortgage loan originations 47 Loan originations totaled 47 Testim R 47 Visa indemnification 47 nonaccruals 47 % miconazole nitrate 47 Tubing Segment 47 Teekay Parent 47 bps yoy 47 IVUS disposable 47 BioGlue R 47 Agilysys NASDAQ AGYS 47 Operational EBITDA 47 sunitinib sorafenib 47 dunnage bag 47 DAC unlock 47 SPN Resources 47 UILIC 47 Engineered Support Structures 47 unabsorbed fixed overhead 47 bln.togrogs 47 LIFO expense 47 Q1 FY'# 47 Q3 F# 47 segment Accredo Health 47 Diavik Joint Venture 47 unannualized 47 b Relates 47 noncash goodwill impairment 47 unrealized depreciation 47 CHF #'#'# 47 intercompany receivables 47 transacting ATMs 47 foodservice glassware 47 TSX ATP.DB 47 gross margin 47 CRINONE ® 8 47 Separation Filtration Systems 47 Q2 #F 47 JPY3 47 excluding goodwill impairment 47 Hugoton Properties 47 #-#/# EUR 47 Qtr Qtr Year 47 Armtec division 47 OREO properties 47 DJOFL 47 AndersElite 47 CYP #k 47 YTD Fiscal 47 #,#.# MEUR 47 Proha Group 47 MDP Transaction 47 repricing downward 47 EUR#.# mn [002] 47 #Q/# [001] 47 Ps.#.# [002] 47 Salix Pharmaceuticals NASDAQ SLXP 47 flattish sequentially 47 thousand BOEPD 47 intersegment eliminations 47 SEK -#.# [001] 47 Essex Chemis AG 47 Akorn Strides 47 FORE SIGHT 47 SmartGrowth Deposits 47 Photop 47 principally attributable 47 Autotype 47 Quality Process Improvement 47 EBITDAC 47 Gross Premiums Written 47 cedant 47 Bushman Tanks 47 Aprovel R 47 Zinc Specialties 47 LIFO provision 47 expenses totaled Ps 47 Genco Glory 47 principal paydowns 47 Q#/# EUR [001] 47 progesterone gel 47 SEK1 #m 47 noncovered loans 47 OICM turnover totaled 47 Healive R 47 USOGP 47 Shanxi Puda Coal 47 Currency translation 47 generation OSV dayrates 47 CNOA shareholders 47 Acticoat TM dressings 47 Dalian Huiming 47 EUR1 #.#m 47 Memorialization products 47 Willi Food commented 47 International Soup Sauces 47 ADMTs 47 JAMBA JUICE 47 NASDAQ GS IPAR 47 noninterest expense partially offset 47 operated bakery cafes 47 TeamStaff GS 47 HH #H helicopters 47 RYZOLT TM 47 #bps YoY [002] 47 Oilseeds Processing 47 Infrared Optics 47 and#.# [002] 47 Eltek commented 47 global Biocides 47 EUR -#.# [001] 47 Almay color 47 iSeries midrange servers 47 Embosphere R 47 nonroutine income 47 Nagase Landauer 47 Possible Loan Losses 47 operated REVPAR 47 UltraLine Series3 47 AMEX ABL 47 nondeductible expenses 47 Copano commodity 47 outstanding DSOs 47 Prepaid Processing 47 Finite Risk segment 47 CAP REIT Announces 47 Xphase 47 #.#bn rub [004] 47 noncash goodwill 47 SUREWEST COMMUNICATIONS 47 cardiovascular cerebrovascular 47 excluding reimbursables 47 Pro forma EBITDA 47 Successor Period 47 Derivative Liabilities 47 Downstream CCS 47 DUV backlog 47 MEEI litigation 47 endedSeptember 47 Canexus LP 47 Diluted HEPS 47 GAAP Adj 47 added distributors VADs 47 c Reflects 47 Tivoli Lotus 47 Lease Losses totaled 47 xxxii 47 Nonoperating expenses 47 CHF#.#bn [002] 47 hopper railcar 47 Fx adj 47 Comparable coffeehouse 47 Bezeq Fixed Line 47 LAAP region 47 retroactive billings 47 RUR#.# [002] 47 Wireline Networking 47 rebased amounts 46 ZAR#.# [005] 46 HERCULES OFFSHORE INC. AND 46 normalized FFO 46 PGS Onshore acquisition 46 Frozen Bakery 46 MGI PHARMA marketed 46 Metretek Florida 46 CHF #.#M 46 ` #cr [002] 46 BioNeurology 46 Dropdown Predecessor 46 Sensata Technologies BV 46 early extinguishments 46 NOL carryforwards 46 FIFO gross 46 clobetasol propionate Foam 46 excluding WStore 46 accrual reversal 46 nonrecourse mortgage 46 Q3 YTD 46 NXP Wireless 46 NOK#.# [005] 46 BGN #.#bn 46 receivables securitization facility